HEALTH

P&G recalls nasal decongestant spray

BY Allison Cerra

CINCINNATI Procter & Gamble voluntarily recalled its 4-hour decongestant nasal spray, a product distributed nationwide in the United States.

P&G said it is taking this voluntary precautionary step after finding that the product formulation for VapoSpray 4-hour nasal spray by Sinex may not meet the expiration dates on the package. This recall is not a result of consumer complaints, the company noted.

 

Consumers who have product with the UPC codes listed below and marked with an expiration date prior to June 2013 should simply discard the affected product:

  • VapoSpray 4-hour nasal spray by Sinex with a UPC code of 3 23900 00082 7. Prior to June 2009, this product was also sold as Sinex Nasal Spray in both a spray (UPC Code 3 23900 00082 7) and Ultra Fine Mist package (UPC Code 3 23900 00085 8).

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

GSK licenses OTC Xerclear; U.S. market excluded

BY Michael Johnsen

LONDON GlaxoSmithKline on Wednesday announced an exclusive agreement for the over-the-counter rights to Medivir’s cold sore treatment Xerclear (acyclovir and hydrocortisone) in key global markets. The trade name in the U.S. market is Lipsovir, which was approved as a prescription remedy for the prevention of cold sores in July 2009.

Under the terms of the agreement, GSK gains exclusive rights to market and distribute non-prescription Xerclear as part of the Zovirax franchise, across multiple markets, including Europe, Russia, Japan, India, Australia and New Zealand. The agreement excludes North and South America, China, South Korea and Israel.

“This alliance demonstrates GSK’s ongoing commitment to invest in and expand our OTC business.  It will help strengthen our dermatology portfolio across multiple territories including several key emerging markets,” stated John Clarke, president, GSK Consumer Healthcare.

GSK will assume responsibility for funding ongoing and future development of Xerclear in all territories covered by the agreement.

Xerclear is the first and only topical herpes labialis (cold sores) treatment clinically proven to help prevent cold sore lesions appearing, GSK stated.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Gaia Herbs debuts new look and Meet Your Herbs program

BY Michael Johnsen

BREVARD, N.C. Gaia Herbs on Tuesday announced the launch of its new branding, new packaging and a new industry-first herb traceability program called Meet Your Herbs.

Meet Your Herbs will provide lot-by-lot, consumer-accessible traceability of the regional origin, harvest story and quality test results of the company’s herbal ingredients and finished products. Consumers and retailers will be able to retrieve information about the company’s products by entering an ID number from the package into the “Meet Your Herbs” field on the company’s website or through a new mobile device application. A demo of the traceability feature is available at Gaia Herb’s new website, New.GaiaHerbs.com

“We believe that every herb needs to be held to the highest standards of purity and integrity in order to ensure maximum potency and results for our consumers,” stated Ric Scalzo, CEO of Gaia Herbs. “We also feel that it is not enough to simply state these claims, so we are offering accountability through complete transparency with our Meet Your Herbs traceability program.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?